CD8 + T cells of patients treated within a few weeks from HIV-1 acquisition or in the chronic phase of infection both exhibit phenotypic abnormalities including upregulation of exhaustion markers21 and soluble markers of inflammation can still be detected in these patients22. The gene discussed is CD8A; the disease is infection.